The use of patient–reported outcome measures in assessing the prevalence and tolerance of SSRI–related sexual dysfunction: a systematic review
Abstract
INTRODUCTION: Selective serotonin reuptake inhibitors (SSRIs) are associated with sexual dysfunction (SD) which can impact patient wellbeing and treatment compliance. Patient-reported outcome measures (PROMs) can be valuable in ensuring sexual functioning is robustly assessed in clinical practice and research. The current review aims to synthesize and evaluate the evidence base regarding the use of PROMs in assessing SSRI-related SD. METHODS: A systematic literature review was conducted using EMBASE, MEDLINE Ultimate, PsycINFO, CINAHL Ultimate, and OpenDissertations to identify which sexual functioning PROMs have been used to assess SSRI-related SD, and what the results indicate regarding the prevalence and tolerance of SD. RESULTS: Twenty seven articles were eligible for inclusion, and the results were evaluated and summarized using a narrative and visual synthesis. Ten PROMs were identified, varying significantly in their comprehensiveness in assessing possible sexual concerns. SSRI-associated SD is prevalent across studies, though tolerance of SD was only reported in 8 studies. DISCUSSION: Existing PROMs are a feasible method for collecting patient-reported data on sexual functioning at baseline and post-treatment in clinical trials of SSRIs. Tolerance of sexual side effects should be carefully considered when assessing patient outcomes, and caution is advised when interpreting outcomes for patients with SD at baseline.
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Improving the translation of search strategies using the Polyglot Search Translator: a randomized controlled trial
- Nutritional, Physical, Cognitive, and Combination Interventions and Frailty Reversal Among Older Adults: A Randomized Controlled Trial
- Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
- A randomized, controlled trial of oral propranolol in infantile hemangioma
- Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study
- Increased physical activity improves sleep and mood outcomes in inactive people with insomnia: a randomized controlled trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.